Humacyte (HUMA) News Today → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free HUMA Stock Alerts $7.50 +0.23 (+3.16%) (As of 10:49 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6, 2024 | americanbankingnews.comBrady W. Dougan Acquires 2,362 Shares of Humacyte, Inc. (NASDAQ:HUMA) StockJune 6, 2024 | americanbankingnews.comHumacyte (NASDAQ:HUMA) Trading Down 14.8% on Insider SellingJune 5, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Stock Price Up 10.9%Humacyte (NASDAQ:HUMA) Trading Up 10.9%June 5, 2024 | insidertrades.comHumacyte, Inc. (NASDAQ:HUMA) Director Buys $14,998.70 in StockJune 5, 2024 | americanbankingnews.comHumacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 809,786 SharesJune 5, 2024 | americanbankingnews.comHeather Ledbetter Prichard Sells 188,886 Shares of Humacyte, Inc. (NASDAQ:HUMA) StockJune 4, 2024 | marketbeat.comHumacyte, Inc. (NASDAQ:HUMA) Director Brady W. Dougan Purchases 2,362 SharesHumacyte, Inc. (NASDAQ:HUMA - Get Free Report) Director Brady W. Dougan bought 2,362 shares of the company's stock in a transaction that occurred on Tuesday, June 4th. The shares were purchased at an average cost of $6.35 per share, for a total transaction of $14,998.70. Following the acquisition, the director now owns 240,832 shares of the company's stock, valued at $1,529,283.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.June 4, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Shares Down 14.8% on Insider SellingHumacyte (NASDAQ:HUMA) Shares Down 14.8% on Insider SellingJune 4, 2024 | americanbankingnews.comShort Interest in Humacyte, Inc. (NASDAQ:HUMA) Decreases By 6.7%June 4, 2024 | insidertrades.comHumacyte, Inc. (NASDAQ:HUMA) CEO Acquires $15,108.50 in StockJune 3, 2024 | marketbeat.comHumacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Buys 2,050 SharesHumacyte, Inc. (NASDAQ:HUMA - Get Free Report) CEO Laura E. Niklason acquired 2,050 shares of the stock in a transaction dated Monday, June 3rd. The stock was acquired at an average cost of $7.37 per share, with a total value of $15,108.50. Following the completion of the transaction, the chief executive officer now owns 238,470 shares in the company, valued at approximately $1,757,523.90. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.June 3, 2024 | marketbeat.comHumacyte, Inc. (NASDAQ:HUMA) Sees Large Drop in Short InterestHumacyte, Inc. (NASDAQ:HUMA - Get Free Report) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 4,190,000 shares, a decline of 6.7% from the April 30th total of 4,490,000 shares. Approximately 4.6% of the shares of the stock are sold short. Based on an average daily volume of 1,740,000 shares, the short-interest ratio is presently 2.4 days.June 2, 2024 | americanbankingnews.comHumacyte (NASDAQ:HUMA) Shares Gap Up to $9.10May 30, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Sees Large Volume IncreaseHumacyte (NASDAQ:HUMA) Sees Strong Trading VolumeMay 30, 2024 | globenewswire.comHumacyte to Present at the Jefferies Global Healthcare ConferenceMay 29, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Sets New 12-Month High at $7.80Humacyte (NASDAQ:HUMA) Hits New 52-Week High at $7.80May 24, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Receives Buy Rating from BenchmarkBenchmark reaffirmed a "buy" rating and issued a $15.00 price target on shares of Humacyte in a research note on Friday.May 22, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Trading 7.3% Higher Humacyte (NASDAQ:HUMA) Shares Up 7.3%May 21, 2024 | finance.yahoo.comThis Humacyte Insider Increased Their Holding By 91% Last YearMay 20, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Hits New 12-Month High at $7.10Humacyte (NASDAQ:HUMA) Reaches New 1-Year High at $7.10May 17, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Shares Down 3.4% Humacyte (NASDAQ:HUMA) Trading Down 3.4%May 17, 2024 | insidertrades.comGordon M. Binder Purchases 50,000 Shares of Humacyte, Inc. (NASDAQ:HUMA) StockMay 16, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Shares Up 6.2% After Insider Buying ActivityHumacyte (NASDAQ:HUMA) Shares Up 6.2% on Insider Buying ActivityMay 14, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Shares Gap Up to $5.48Humacyte (NASDAQ:HUMA) Shares Gap Up to $5.48May 14, 2024 | msn.comHumacyte extends gains as FDA reviews blood vessel productMay 13, 2024 | markets.businessinsider.comBenchmark Co. Keeps Their Buy Rating on Humacyte (HUMA)May 13, 2024 | msn.comHumacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call TranscriptMay 13, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Hits New 12-Month High at $5.09Humacyte (NASDAQ:HUMA) Reaches New 52-Week High at $5.09May 13, 2024 | finance.yahoo.comHumacyte Inc (HUMA) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...May 13, 2024 | finance.yahoo.comHumacyte to Participate at Upcoming Investor Conferences in MayMay 13, 2024 | globenewswire.comHumacyte to Participate at Upcoming Investor Conferences in MayMay 11, 2024 | finance.yahoo.comQ1 2024 Humacyte Inc Earnings CallMay 10, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Trading Up 6.2%Humacyte (NASDAQ:HUMA) Shares Up 6.2%May 10, 2024 | benzinga.comPeering Into Humacyte's Recent Short InterestMay 10, 2024 | finance.yahoo.comHumacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic AdvancesMay 10, 2024 | msn.comHumacyte GAAP EPS of -$0.29 misses by $0.06May 10, 2024 | globenewswire.comHumacyte First Quarter 2024 Financial Results and Business UpdateMay 9, 2024 | msn.comHumacyte Q1 2024 Earnings PreviewMay 7, 2024 | marketbeat.comHumacyte (HUMA) to Release Quarterly Earnings on FridayHumacyte (NASDAQ:HUMA) will be releasing earnings before the market opens on Friday, May 10, Zacks reports.May 6, 2024 | globenewswire.comHumacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024May 1, 2024 | marketbeat.comHumacyte (NASDAQ:HUMA) Trading Up 7.4%Humacyte (NASDAQ:HUMA) Stock Price Up 7.4%April 20, 2024 | msn.comA U.S. Senator Just Bought this Tiny Stock – It’s Up 15% TodayApril 18, 2024 | msn.comA U.S. Senator Just Bought this Tiny Stock - It's Up 15% TodayApril 18, 2024 | benzinga.comAlly Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On ThursdayApril 18, 2024 | msn.comTuberville’s Trading Raises Questions: Senator Sells Put Options, Invests in Small Biotech Tied to Ukraine-Russia ConflictApril 17, 2024 | ca.investing.comU.S. Senator Tommy Tuberville Just Reported a Purchase of $HUMA stockApril 15, 2024 | finance.yahoo.comHumacyte, Inc. (HUMA) Interactive Stock Chart - Yahoo FinanceApril 8, 2024 | markets.businessinsider.comOppenheimer Keeps Their Buy Rating on Humacyte (HUMA)April 4, 2024 | marketbeat.comResearch Analysts Set Expectations for Humacyte, Inc.'s FY2024 Earnings (NASDAQ:HUMA)Humacyte, Inc. (NASDAQ:HUMA - Free Report) - Equities research analysts at Cantor Fitzgerald upped their FY2024 earnings per share estimates for Humacyte in a research report issued to clients and investors on Monday, April 1st. Cantor Fitzgerald analyst K. Kluska now expects that the company wilApril 1, 2024 | marketbeat.comHumacyte's (HUMA) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $7.00 target price on shares of Humacyte in a research report on Monday. Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Time is Running Out - June 25th Deadline Approaching! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. That will slam shut June 25. HUMA Media Mentions By Week HUMA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUMA News Sentiment▼0.670.76▲Average Medical News Sentiment HUMA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUMA Articles This Week▼162▲HUMA Articles Average Week Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EVLV News Today DSKE News Today BARK News Today SST News Today BODY News Today IMVT News Today SWTX News Today ACLX News Today APGE News Today DNLI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HUMA) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored